LIGAND PHARMACEUTICALS INCORPORATED Derivative, Gain on Derivative
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Derivative, Gain on Derivative of $1.20 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainOnDerivative · last filed 2025-08-08
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain on derivative for the quarter ending 2024-06-30 was $1.20M.
| Period end | Derivative, Gain on Derivative 3 month | Derivative, Gain on Derivative 6 month |
|---|---|---|
| 2024-06-30 | $1.20M 10-Q · filed 2025-08-08 | $1.20M 10-Q · filed 2025-08-08 |